CAS 117086-68-7

Ricasetron

Description:

Ricasetron is a chemical compound classified as a selective serotonin 5-HT3 receptor antagonist, primarily used in the context of pharmacology to prevent nausea and vomiting, particularly in patients undergoing chemotherapy or surgery. Its mechanism of action involves blocking the 5-HT3 receptors in the central nervous system and gastrointestinal tract, which are involved in the vomiting reflex. Ricasetron is characterized by its high affinity for these receptors, contributing to its effectiveness in managing emesis. The compound is typically administered orally or intravenously, depending on the clinical scenario. In terms of its chemical structure, Ricasetron features a distinct arrangement of atoms that contributes to its biological activity, although specific structural details are not provided here. As with many pharmaceuticals, potential side effects may include headache, constipation, or dizziness, and it is essential to consider drug interactions when prescribing. Overall, Ricasetron represents a significant advancement in the management of nausea and vomiting associated with various medical treatments.

Formula: C₁₉H₂₇N₃O

InChI: InChI=1/C19H27N3O/c1-19(2)12-22(17-7-5-4-6-16(17)19)18(23)20-13-10-14-8-9-15(11-13)21(14)3/h4-7,13-15H,8-12H2,1-3H3,(H,20,23)/t13-,14+,15-

InChI key: InChIKey=ILXWRFDRNAKTDD-QDMKHBRRNA-N

SMILES: C(N[C@H]1C[C@@]2(N(C)[C@](C1)(CC2)[H])[H])(=O)N3C=4C(C(C)(C)C3)=CC=CC4

Synonyms:

• Ricasetron
• 1H-Indole-1-carboxamide, 2,3-dihydro-3,3-dimethyl-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-, endo-
• 2,3-Dihydro-3,3-dimethyl-N-[(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl]-1H-indole-1-carboxamide
• BRL 46470
• 1H-Indole-1-carboxamide, 2,3-dihydro-3,3-dimethyl-N-[(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl]-

Ricasetron

CAS: 117086-68-7

Ricasetron

Purity: ≥98%

Molecular weight: 313.44g/mol

Ref: 54-BUP03256

Ricasetron

CAS: 117086-68-7

Ricasetron is a type of serotonin receptor antagonist that is used to prevent nausea and vomiting caused by certain types of chemotherapy, which are known as emetogenic. Ricasetron is an ion-pair reconstituted drug that binds to the 5-HT4 receptor in the gastrointestinal tract. This prevents serotonin from binding to the receptor, preventing nausea and vomiting. Ricasetron has also been shown to decrease appetite, which may be due to its effects on neurokinin-1 (NK1). Ricasetron has been clinically proven for use in patients with cancer who are receiving chemotherapy.
Ricasetron is a type of fatty acid that is used as a chemical structure in various medications. It was first synthesized in 1972 by scientists at Sandoz Pharmaceuticals AG and was patented in 1974.

Formula: C₁₉H₂₇N₃O

Purity: Min. 95%

Molecular weight: 313.4 g/mol

Ref: 3D-SEA08668

Ricasetron

CAS: 117086-68-7

Ricasetron (Brl 46470) is a 5-HT3 receptor antagonist with pro-axonal lysing properties and is used in the study of anxiety disorders and anxiety disorders.

Formula: C₁₉H₂₇N₃O

Purity: 99.52%

Color and Shape: Solid

Molecular weight: 313.44

Ref: TM-T28537